FOxTROT Trial Sheds Light on Neoadjuvant Therapy for CRC FOxTROT Trial Sheds Light on Neoadjuvant Therapy for CRC

David J. Kerr, CBE, MD, DSc, discusses lessons learned from the FOxTROT trial, and future directions.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news